TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Epicept Investors Still Waiting on News of a Partner VFC submits: Shares of Epicept (EPCT) have logged quite the volatile week of trading after a price spike carried shares to near the $1 mark before immediately retreating to the eighty cent level.A press release was issued on Thursday by the company highlighting some recent positive recognition for Ceplene, Epicept's treatment for adult patients with Acute Myeloid Leukemia (AML) in first remission, but as I've stated before - the only news investors want to hear at this point regarding Ceplene is news of a commercial partner in Europe. According to Thursday's PR, the company is (as quoted from the PR) "still in negotiations with several prospective partners;" just as they have been all year.Complete Story » seekingalpha.com |
11 Ache-Free Investment Opportunities in Neuropathic Pain Michael Becker submits:Co-authored by Michael D. Becker, Jeffrey Martini, Ph.D., and Janet L. Dally In the United States, up to 50 million people live with chronic pain, with the majority of these patients not satisfied with their current pain treatments. Pain is defined clinically as an unpleasant emotional experience resulting from real or potential tissue damage and is generally divided into two categories based on cause:Complete Story » seekingalpha.com |
Republicans Target AARP Insurance Ties Republicans in Congress are taking aim at AARP's financial ties to the health-insurance industry just as the advocacy group is taking a more prominent role supporting an overhaul of the nation's health-care system. online.wsj.com |
N.J. Likely to Allow Medical Marijuana New Jersey is poised to become the latest state to allow medical marijuana for certain serious diseases. online.wsj.com |
Walgreen to Test Diabetes Services People with Type 2 diabetes will have an opportunity for personal consultations with Walgreen pharmacists and nurse practitioners under a new pilot program. online.wsj.com |